Stay updated on Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.

Latest updates to the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedFive new Virginia sites were added (Williamsburg, Newport News, Hampton, Chesapeake, Virginia Beach), bringing the total locations to 93. The study record was updated to revision v3.5.0 with completion dates noted.SummaryDifference0.6%

- Check26 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3. This appears to be an administrative update to the page with no changes to study data.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 to the site; removed the government funding lapse notice and the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedAdded a government funding lapse notice at the top of the page. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check68 days agoChange DetectedMinor UI and metadata updates include a glossary display, new QC-related metadata labels, and a revision bump to v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page. No substantive study content was changed.SummaryDifference0.0%

Stay in the know with updates to Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.